Ramipril

In the US, Ramipril (ramipril systemic) is a member of the drug class angiotensin converting enzyme inhibitors and is used to treat Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:

• Ramipril


• Ramipril Capsules

UK matches:

• Ramipril 1.25mg, 2.5mg, 5mg & 10mg Capsules
• Ramipril 1.25mg, 2.5mg, 5mg & 10mg Tablets
• Ramipril Capsules 1.25mg, 2.5mg, 5mg, 10mg (Actavis UK Ltd)
• Ramipril Tablets 1.25mg, 2.5mg, 5mg, 10mg (Actavis UK Ltd)
• Ramipril 1.25 mg Capsules (SPC)
• Ramipril 1.25mg Tablets (SPC)
• Ramipril 10 mg Capsules (SPC)
• Ramipril 10mg Tablets (SPC)
• Ramipril 2.5 mg Capsules (SPC)
• Ramipril 2.5mg Tablets (SPC)
• Ramipril 5 mg Capsules (SPC)
• Ramipril 5mg Tablets (SPC)

Ingredient matches for Ramipril

Ramipril

Ramipril (BAN, DCF, USAN) is known as Ramipril in the US.

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Ramipril in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.